Skip to main content

ADVERTISEMENT

Jeremy Schafer, PharmD, MBA

Pharma Insights
08/19/2019
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value assessment in oncology is an emerging area of interest. Multiple value frameworks have been launched in the past 5 years to help stakeholders analyze the cost-effectiveness, or affordability, of oncology...
Value...
08/19/2019
Journal of Clinical Pathways
Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving
Pharma Insights
03/16/2020
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...
The...
03/16/2020
Journal of Clinical Pathways
Pharma Insights
08/02/2016
Attributing value in the rapidly expanding oncology space is a new challenge to payers looking to introduce a range of novel therapies where older drugs have long dominated. Rising costs across all levels of cancer...
Attributing value in the rapidly expanding oncology space is a new challenge to payers looking to introduce a range of novel therapies where older drugs have long dominated. Rising costs across all levels of cancer...
...
08/02/2016
Journal of Clinical Pathways
Pharma Insights
09/06/2016
Controversy over the lack of a survival benefit associated with early diagnosis of prostate cancer through prostate-specific antigen (PSA) screening has led to uncertainty in the determination of PSA coverage and its...
Controversy over the lack of a survival benefit associated with early diagnosis of prostate cancer through prostate-specific antigen (PSA) screening has led to uncertainty in the determination of PSA coverage and its...
...
09/06/2016
Journal of Clinical Pathways
Pharma Insights
03/15/2017
All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...
All members of the health care community must play a role in antimicrobial stewardship. The payer role is to monitor appropriate antibiotic use, encourage low-cost options, and help to facilitate the transition of...
All...
03/15/2017
Journal of Clinical Pathways